Innate Pharma SA (IPHA)
2.20
+0.05
(+2.33%)
USD |
NASDAQ |
Sep 27, 16:00
2.19
-0.01
(-0.45%)
Pre-Market: 20:00
Innate Pharma Net Income (Quarterly)
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
April 30, 2021 | 39.13M |
January 31, 2021 | 36.69M |
October 31, 2020 | 47.16M |
July 31, 2020 | 51.16M |
April 30, 2020 | 36.21M |
January 31, 2020 | 26.56M |
Date | Value |
---|---|
October 31, 2019 | 32.65M |
July 31, 2019 | 34.54M |
April 30, 2019 | 26.14M |
January 31, 2019 | 24.81M |
October 31, 2018 | 41.08M |
July 31, 2018 | 48.83M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
26.56M
Minimum
Jan 2020
51.16M
Maximum
Jul 2020
38.51M
Average
36.69M
Median
Jan 2021
Net Income (Quarterly) Benchmarks
DBV Technologies SA | -33.12M |
Cellectis SA | -25.27M |
Genfit SA | -- |
Inventiva SA | -- |
Nanobiotix SA | -- |
Net Income (Quarterly) Related Metrics
Enterprise Value | 117.75M |
Earnings Yield | -20.56% |
Normalized Earnings Yield | -20.56 |